Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank56
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Latest
$-5.03M
↓ 103% vs avg
Percentile
P56
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$195.30M
Historical baseline
PeriodValueYoY Change
TTM$-5.03M-100.2%
2024$2.02B+9947.4%
2023$-20.50M-27.3%
2022$-16.11M-209.6%
2021$-5.20M+36.5%
2020$-8.19M-20.7%
2019$-6.79M-380.7%
2018$-1.41M+32.8%
2017$-2.10M-184.4%
2016$-739000.00-